Patent · US Active

Use for budesonide and formoterol

US8461211B2 · kind B2 · utility

6Cited by
6References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 30, 2010
Grant dateJun 11, 2013
Priority date—
Expiry dateDec 30, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P11/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides the use of formoterol and budesonide in the treatment of chronic obstructive pulmonary disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.